Great Bay Bio Completes First Close of Series B Financing

Great Bay Bio Completes First Close of Series B Financing

HONG KONG, Dec. 17, 2024 /PRNewswire/ -- Great Bay Bio (GBB) is thrilled to announce the successful first close of its Series B financing round. This milestone was achieved with the round led by a syndication of a well-known strategic investment...

Cheetah Mobile Announces Third Quarter 2024 Unaudited Consolidated Financial Results

Cheetah Mobile Announces Third Quarter 2024 Unaudited Consolidated Financial Results

BEIJING, Dec. 17, 2024 /PRNewswire/ -- Cheetah Mobile Inc. (NYSE: CMCM) ("Cheetah Mobile" or the "Company"), a China-based IT company, today announced its unaudited consolidated financial results for the third quarter ended September 30, 2024....

Saudi Arabia announces for the world Riyadh Declaration for an inclusive, innovative and impactful AI for all

Saudi Arabia announces for the world Riyadh Declaration for an inclusive, innovative and impactful AI for all

RIYADH, Saudi Arabia, Dec. 17, 2024 /PRNewswire/ -- The Kingdom of Saudi Arabia announced the "Riyadh Declaration" at the beginning of the 19th session of the Internet Governance Forum (IGF Riyadh 2024), hosted in Riyadh, organized by the United...

Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY® by the National Medical Products Administration of China for the Treatment of Moderately to Severely Active Ulcerative Colitis

Everest Medicines Announces Acceptance of the New Drug Application for VELSIPITY® by the National Medical Products Administration of China for the Treatment of Moderately to Severely Active Ulcerative Colitis

SHANGHAI, Dec. 17, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today...

QUALITY HORTICULTURE ANNOUNCES PREMIUM BRAND PORTFOLIO EXPANSION INTO USA

QUALITY HORTICULTURE ANNOUNCES PREMIUM BRAND PORTFOLIO EXPANSION INTO USA

ONTARIO, Calif., Dec. 17, 2024 /PRNewswire/ -- Quality Horticulture Ltd. ("Quality"), a leading independent distributor of controlled environment agriculture equipment, lighting, fertilizers and grow media, today announced it has expanded its...

MMA Global Announces the SMARTIES™ X Global & North America 2024 Winners: A Celebration of Marketing Excellence - Pushing Innovative Boundaries on the Global Stage

MMA Global Announces the SMARTIES™ X Global & North America 2024 Winners: A Celebration of Marketing Excellence - Pushing Innovative Boundaries on the Global Stage

NEW YORK, Dec. 17, 2024 /PRNewswire/ -- MMA Global proudly announces the winners of the esteemed SMARTIES™ X Global & North America 2024 Awards. This prestigious program honors the most innovative and impactful marketing campaigns worldwide,...

Peabody Announces First Coal Shipment from Centurion Mine

Peabody Announces First Coal Shipment from Centurion Mine

Marks another major milestone in the redevelopment of the premium steelmaking coal mine ST. LOUIS, Dec. 17, 2024 /PRNewswire/ -- Peabody (NYSE: BTU) today announced that it has successfully shipped the first product from its Centurion Mine in...

Microbio Co., Ltd. (4128) Announces Promising Results of "MS-20" in Combination with Keytruda for Stage IIIb/IV Non-Small Cell Lung Cancer

Microbio Co., Ltd. (4128) Announces Promising Results of "MS-20" in Combination with Keytruda for Stage IIIb/IV Non-Small Cell Lung Cancer

CUPERTINO, Calif., Dec. 17, 2024 /PRNewswire/ -- Microbio Co., Ltd. (4128) today revealed encouraging results from an exploratory clinical trial of MS-20 combined with Keytruda (pembrolizumab) in stage IIIb/IV non-small cell lung cancer (NSCLC). The...

Menarini Group announces Positive Topline Data from Pivotal Phase 3 BROADWAY & TANDEM Clinical Trials Evaluating Obicetrapib and the Fixed-Dose Combination Obicetrapib with Ezetimibe 10 mg

Menarini Group announces Positive Topline Data from Pivotal Phase 3 BROADWAY & TANDEM Clinical Trials Evaluating Obicetrapib and the Fixed-Dose Combination Obicetrapib with Ezetimibe 10 mg

– Both pivot al studies achieved primary endpoints of LS mean reduction in LDL-C on top of maximally tolerated lipid-modifying therapies with high statistical significance (p<0.0001) – Approximately 50% of patients in BROADWAY (Obicetrapib...

MSquare Announces Strategic Partnership with ADTechnology at ICCAD 2024

MSquare Announces Strategic Partnership with ADTechnology at ICCAD 2024

SHANGHAI, Dec. 16, 2024 /PRNewswire/ -- At the ICCAD 2024, MSquare Technology (MSquare) proudly unveiled its strategic partnership with ADTechnology, a global leader in semiconductor design solutions. The partnership marks a significant milestone in...

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...
  • 20
  • menu
    menu